Literature DB >> 26285186

Variation across Canada in the economic burden attributable to excess weight, tobacco smoking and physical inactivity.

Hans Krueger1, Joshua Krueger, Jacqueline Koot.   

Abstract

OBJECTIVES: Tobacco smoking, excess weight and physical inactivity contribute substantially to the preventable disease burden in Canada. The purpose of this paper is to determine the potential reduction in economic burden if all provinces achieved prevalence rates of these three risk factors (RFs) equivalent to those of the province with the lowest rates, and to update and address a limitation noted in our previous model.
METHODS: We used a previously developed approach based on population attributable fractions to estimate the economic burden associated with these RFs. Sex-specific relative risk and age-/sex-specific prevalence data were used in the modelling. The previous model was updated using the most current data for developing resource allocation weights.
RESULTS: In 2012, the prevalence of tobacco smoking, excess weight and physical inactivity was the lowest in British Columbia. If age- and sex-specific prevalence rates from BC were applied to populations living in the other provinces, the annual economic burden attributable to these three RFs would be reduced by $5.3 billion. Updating the model resulted in a considerable shift in economic burden from smoking to excess weight, with the estimated annual economic burden attributable to excess weight now 25% higher compared to that of tobacco smoking ($23.3 vs. $18.7 billion).
CONCLUSION: Achieving RF prevalence rates equivalent to those of the province with the lowest rates would result in a 10% reduction in economic burden attributable to excess weight, smoking and physical inactivity in Canada. This study shows that using current resource use data is important for this type of economic modelling.

Entities:  

Keywords:  Economic burden of disease; obesity; overweight; populations at risk; risk factors; smoking

Mesh:

Year:  2015        PMID: 26285186      PMCID: PMC6972221          DOI: 10.17269/cjph.106.4994

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  15 in total

1.  The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia.

Authors:  R Goeree; B J O'Brien; G Blackhouse; K Agro; P Goering
Journal:  Can J Psychiatry       Date:  1999-06       Impact factor: 4.356

2.  The economic costs associated with physical inactivity and obesity in Canada: an update.

Authors:  Peter T Katzmarzyk; Ian Janssen
Journal:  Can J Appl Physiol       Date:  2004-02

3.  Improved estimation of the health and economic burden of chronic disease risk factors in Manitoba.

Authors:  H Krueger; D Williams; A E Ready; L Trenaman; D Turner
Journal:  Chronic Dis Inj Can       Date:  2013-09

Review 4.  Valuing patient and caregiver time: a review of the literature.

Authors:  Jennifer E Tranmer; Denise N Guerriere; Wendy J Ungar; Peter C Coyte
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Stephen S Lim; Theo Vos; Abraham D Flaxman; Goodarz Danaei; Kenji Shibuya; Heather Adair-Rohani; Markus Amann; H Ross Anderson; Kathryn G Andrews; Martin Aryee; Charles Atkinson; Loraine J Bacchus; Adil N Bahalim; Kalpana Balakrishnan; John Balmes; Suzanne Barker-Collo; Amanda Baxter; Michelle L Bell; Jed D Blore; Fiona Blyth; Carissa Bonner; Guilherme Borges; Rupert Bourne; Michel Boussinesq; Michael Brauer; Peter Brooks; Nigel G Bruce; Bert Brunekreef; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Fiona Bull; Richard T Burnett; Tim E Byers; Bianca Calabria; Jonathan Carapetis; Emily Carnahan; Zoe Chafe; Fiona Charlson; Honglei Chen; Jian Shen Chen; Andrew Tai-Ann Cheng; Jennifer Christine Child; Aaron Cohen; K Ellicott Colson; Benjamin C Cowie; Sarah Darby; Susan Darling; Adrian Davis; Louisa Degenhardt; Frank Dentener; Don C Des Jarlais; Karen Devries; Mukesh Dherani; Eric L Ding; E Ray Dorsey; Tim Driscoll; Karen Edmond; Suad Eltahir Ali; Rebecca E Engell; Patricia J Erwin; Saman Fahimi; Gail Falder; Farshad Farzadfar; Alize Ferrari; Mariel M Finucane; Seth Flaxman; Francis Gerry R Fowkes; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Santu Ghosh; Edward Giovannucci; Gerhard Gmel; Kathryn Graham; Rebecca Grainger; Bridget Grant; David Gunnell; Hialy R Gutierrez; Wayne Hall; Hans W Hoek; Anthony Hogan; H Dean Hosgood; Damian Hoy; Howard Hu; Bryan J Hubbell; Sally J Hutchings; Sydney E Ibeanusi; Gemma L Jacklyn; Rashmi Jasrasaria; Jost B Jonas; Haidong Kan; John A Kanis; Nicholas Kassebaum; Norito Kawakami; Young-Ho Khang; Shahab Khatibzadeh; Jon-Paul Khoo; Cindy Kok; Francine Laden; Ratilal Lalloo; Qing Lan; Tim Lathlean; Janet L Leasher; James Leigh; Yang Li; John Kent Lin; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Joelle Mak; Reza Malekzadeh; Leslie Mallinger; Wagner Marcenes; Lyn March; Robin Marks; Randall Martin; Paul McGale; John McGrath; Sumi Mehta; George A Mensah; Tony R Merriman; Renata Micha; Catherine Michaud; Vinod Mishra; Khayriyyah Mohd Hanafiah; Ali A Mokdad; Lidia Morawska; Dariush Mozaffarian; Tasha Murphy; Mohsen Naghavi; Bruce Neal; Paul K Nelson; Joan Miquel Nolla; Rosana Norman; Casey Olives; Saad B Omer; Jessica Orchard; Richard Osborne; Bart Ostro; Andrew Page; Kiran D Pandey; Charles D H Parry; Erin Passmore; Jayadeep Patra; Neil Pearce; Pamela M Pelizzari; Max Petzold; Michael R Phillips; Dan Pope; C Arden Pope; John Powles; Mayuree Rao; Homie Razavi; Eva A Rehfuess; Jürgen T Rehm; Beate Ritz; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Jose A Rodriguez-Portales; Isabelle Romieu; Robin Room; Lisa C Rosenfeld; Ananya Roy; Lesley Rushton; Joshua A Salomon; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; Amir Sapkota; Soraya Seedat; Peilin Shi; Kevin Shield; Rupak Shivakoti; Gitanjali M Singh; David A Sleet; Emma Smith; Kirk R Smith; Nicolas J C Stapelberg; Kyle Steenland; Heidi Stöckl; Lars Jacob Stovner; Kurt Straif; Lahn Straney; George D Thurston; Jimmy H Tran; Rita Van Dingenen; Aaron van Donkelaar; J Lennert Veerman; Lakshmi Vijayakumar; Robert Weintraub; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Warwick Williams; Nicholas Wilson; Anthony D Woolf; Paul Yip; Jan M Zielinski; Alan D Lopez; Christopher J L Murray; Majid Ezzati; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

6.  The economic benefits of risk factor reduction in Canada: tobacco smoking, excess weight and physical inactivity.

Authors:  Hans Krueger; Donna Turner; Joshua Krueger; A Elizabeth Ready
Journal:  Can J Public Health       Date:  2014-03-18

7.  Estimates and projections of value of life lost from cancer deaths in the United States.

Authors:  K Robin Yabroff; Cathy J Bradley; Angela B Mariotto; Martin L Brown; Eric J Feuer
Journal:  J Natl Cancer Inst       Date:  2008-12-09       Impact factor: 13.506

8.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06

9.  The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK.

Authors:  Kirstin Pirie; Richard Peto; Gillian K Reeves; Jane Green; Valerie Beral
Journal:  Lancet       Date:  2012-10-27       Impact factor: 79.321

Review 10.  The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis.

Authors:  Daphne P Guh; Wei Zhang; Nick Bansback; Zubin Amarsi; C Laird Birmingham; Aslam H Anis
Journal:  BMC Public Health       Date:  2009-03-25       Impact factor: 3.295

View more
  19 in total

1.  Reducing the economic burden of chronic disease requires major investment in public health.

Authors:  Kim D Raine
Journal:  Can J Public Health       Date:  2015-07-24

2.  Editorial -- The weight of our nation.

Authors:  Hans Krueger
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-02       Impact factor: 3.240

3.  Regional variations in the economic burden attributable to excess weight, physical inactivity and tobacco smoking across British Columbia.

Authors:  H Krueger; J M Koot; D P Rasali; S E Gustin; M Pennock
Journal:  Health Promot Chronic Dis Prev Can       Date:  2016-04       Impact factor: 3.240

4.  How much evidence is enough? A public health perspective on evidence-informed tobacco policy.

Authors:  Robert Schwartz
Journal:  Can J Public Health       Date:  2019-10

5.  The economic burden of cancers attributable to tobacco smoking, excess weight, alcohol use, and physical inactivity in Canada.

Authors:  H Krueger; E N Andres; J M Koot; B D Reilly
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

6.  The association between the cost and quality of diets of children in Canada.

Authors:  Enid Bukambu; Jessica R L Lieffers; John Paul Ekwaru; Paul J Veugelers; Arto Ohinmaa
Journal:  Can J Public Health       Date:  2019-12-13

7.  Exercise as a vital sign: a preliminary pilot study in a chiropractic setting.

Authors:  Scott Howitt; Kyle Simpson; Darren Suderman; Andrew Mercer; Susan Rutherford; Christopher deGraauw
Journal:  J Can Chiropr Assoc       Date:  2017-12

8.  Regional Comparisons of Associations Between Physical Activity Levels and Cardiovascular Disease: The Story of Atlantic Canada.

Authors:  Bartosz Orzel; Melanie Keats; Yunsong Cui; Scott Grandy
Journal:  CJC Open       Date:  2021-01-21

9.  Don't Change Much.

Authors:  H Krueger; S L Goldenberg; J Koot; E Andres
Journal:  Am J Mens Health       Date:  2016-10-04

Review 10.  Economic Burden of Obesity: A Systematic Literature Review.

Authors:  Maximilian Tremmel; Ulf-G Gerdtham; Peter M Nilsson; Sanjib Saha
Journal:  Int J Environ Res Public Health       Date:  2017-04-19       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.